Introduction
Genetic alterations that interfere with the execution of the apoptotic cell death pathway are important components of both the clonal evolution of cancer cells and the response of these cells in patients to therapy (Fisher, 1994; Yang and Korsmeyer, 1996) . One mechanism involved is the response of cells to DNA damage. In normal cells, detection of DNA damage, involving p53 and other proteins, results in the instigation of cell cycle arrest and DNA repair or cell death (Kuerbitz et al., 1992; Paulovich et al., 1997) . These alternative pathways vary in dominance and in hemopoietic cells, the cell death option is frequently adopted. This outcome can however be compromised if key regulatory proteins are dysfunctional. Lack of p53 (Clarke et al., 1993; Griths et al., 1997) or overexpression of BCL-2 protein (Griths et al., 1994a; Merino et al., 1994; Vaux et al., 1988) can, for example, rescue lymphoid cells otherwise destined for destruction following low level exposure to genotoxic chemicals, ionizing irradiation or corticosteroids. The acquisition of such blocks to cell death can have important consequences to both leukaemogenesis, response to genotoxic therapy and further malignant progression. Animals that are homozygous null for p53 are at high risk of developing leukaemia/lymphoma (Donehower et al., 1992; Purdie et al., 1994) and exposure of p53 null lymphocytes in vitro to Xirradiation results in survival of clonogenic mutants that would have died if in a wild-type, p53 competent background (Griths et al., 1997) . These observations suggest that the availability of apoptotic pathways in cells can make a very signi®cant impact on the balance of transformation and cell death outcomes for genotoxic exposures. If this is correct, then mice transgenic for BCL-2 should be considerably more vulnerable to cancer induction by genotoxic exposure than wild-type controls. For example, in the fraction of clonogenic Em-BCL-2 expressing B lineage cells surviving diering doses of X-irradiation there could be cells that had incurred chromosomal/DNA damage that was compatible with continued growth but that included molecular alterations that could contribute to leukaemogenesis. In a normal genetic background, such cells would be eliminated by apoptosis. This idea has not hitherto been assessed. A positive outcome would be instructive for our understanding of mechanisms of leukaemogenesis and perhaps relevant to the susceptibility to leukaemia/lymphoma of normal adult human individuals who have clones of B cells with an endogenous rearranged and activated BCL-2 gene (Ji et al., 1995; Liu et al., 1994) .
Em-BCL-2 transgenic mice constitutively express human BCL-2 protein at high levels in the B cell lineage (McDonnell et al., 1989) . These animals may spontaneously develop B lineage malignancies at a relatively modest rate (5 ± 15%) and with a protracted latency (12 ± 18 months) (McDonnell and Korsmeyer, 1991; Strasser et al., 1993) although a cross between Em-BCL-2 and Em-MYC transgenic mice results in a high rate of leukaemias with a brief latency (Strasser et al., 1990) , indicating that single oncogenes can have highly penetrant eects in the context of expression of an anti-apoptotic gene. We challenged such mice with a single dose of X-irradiation of between 1 and 4 Gray (Gy). We also compared very young mice (4 ± 6 weeks) with adult mice. The rationale here relates to an epidemiological and clinical precedent. Following the atomic bombs dropped on Hiroshima and Nagasaki in 1945, risk of lymphoid malignancy in the form of acute lymphoblastic leukaemia was increased most significantly in those who were young (515 years) at the time of exposure (Boice and Inskip, 1996) implying an increased vulnerability of lymphoid progenitor cell populations to transformation in the young.
Results
We have previously reported that B cell precursors from these Em-BCL-2 transgenic mice are protected from apoptosis following genotoxic exposure (Griths et al., 1994a) . Mice from the same breeding stock were assessed for leukaemogenesis in vivo following radiation.
Frequency, latency and histopathology of leukaemia in X-irradiated Em-BCL-2 mice
No spontaneous lymphoma/leukaemias were observed in 57 non-irradiated Em-BCL-2 mice monitored until 18 months of age. This diers somewhat from the previously reported ®gure of 5 ± 15% for diuse lymphoma, leukaemia or plasmacytoma (McDonnell and Korsmeyer, 1991; Strasser et al., 1993) . This dierence could re¯ect the fact that our mice have been back-crossed for several generations and are genetically distinct. Alternatively, as our mice were maintained in Thoren positive individually ventilated (PIV) cages ensuring a clean and relatively antigen-free environment, it may be that some low level microbial or other antigenic exposure is required for lymphoma/ plasmacytoma development. Following X-irradiation with either 2 or 4 Gy at age 4 ± 6 weeks or 4 ± 6 months, wild-type mice of this genetic background have a very low rate of leukaemia/lymphoma up to 18 months of age (Tables 1 and 2 ). A very dierent response was observed in Em-BCL-2 mice, which was dependent upon age at exposure.
Between 6 ± 12 months after X-irradiation (2 or 4 Gy) of 4 ± 6 week old Em-BCL-2 mice a substantial proportion (*70%) had become morbid with hunched posture, rued fur and obvious splenomegaly (Table  1) . On autopsy, enlarged spleens were usually accompanied with enlarged lymph nodes (lateral and/ or mesentary) and occasional masses of lymphocytes observed in organs such as the liver. The characteristic symptoms of neoplasia in these organs plus others (e.g. kidney) including bone marrow were con®rmed as leukaemia by histopathology of sections that showed lymphoblastic hyperplasia with in®ltration of tissue by the leukaemic blasts and disruption of normal tissue architecture ( Figure 1 ). (In one case, spleen and lymph nodes were in®ltrated with cells bearing a lymphomonocytoid morphology).
The length of latency before emergence of leukaemia after X-irradiation of the 4 ± 6 week old mice was slightly (but not signi®cantly) decreased with increasing doses of X-irradiation (2 Gy versus 4 Gy; Figure 2 ). Em-BCL-2 mice treated with 1 Gy of irradiation did not develop leukaemia (data not shown).
In comparison with mice that were X-irradiated at 4 weeks of age, mice irradiated as adults (4 ± 6 months of age) exhibited a much reduced rate of leukaemia with only 3.5% of Em-BCL-2 transgenic mice irradiated with 2 Gy having leukaemia 12 months after the irradiation (Table 2 ). This ®gure was increased when adult mice were treated with the higher dose of irradiation (4 Gy) although still signi®cantly reduced when compared to Table 2) .
Clonal IGH gene rearrangements in leukaemias
Southern blot analysis of spleen cell DNA using a mouse immunoglobulin heavy chain J H region probe revealed clonal rearrangements ( Figure 3 , Table 3 ). When tested, the same leukaemic clone was detected in dierent tissues from the same transgenic mouse (Figure 3) . Mono-or bi-allelic rearrangements were observed in 20 of 22 leukaemias examined (Figure 3 ), compatible with a single cell or monoclonal origin of the leukaemia in an early lymphoid progenitor. The single tri-allelic rearrangement observed ( Figure 3 , leukaemia #765) might re¯ect either a bi-clonal population or two sub-clones derived from a single progenitor transformed prior to IGH gene rearrangement. The only leukaemia to develop in an adult (4 ± 6 months of age) mouse after 2 Gy irradiation (Table 2) had germ-line, non-rearranged IGH genes.
Immunophenotype of leukaemias induced in Em-BCL-2 transgenic mice
All splenic leukaemic lymphoblasts tested expressed the human BCL-2 transgene encoded protein as assessed by antibody staining (data not shown). The clonal rearrangements observed in Em-BCL-2 mice and the nature of the construct used (i.e. Em-dependent expression) led us to assume that the leukaemias might all represent one or more stages of B lineage development. Their lymphoblastic morphology also suggests a parallel with acute lymphoblastic leukaemia (ALL) in humans which is a lymphoid (primarily B) precursor cell disease (Greaves, 1986) . Surprisingly, however, the majority of the leukaemias in mice irradiated with 2 or 4 Gy exhibited immunophenotypic features of early B lympho-myeloid progenitor population, with one exception (Table 3) . The leukaemic population was negative for the lineagespeci®c B lymphocyte precursor markers including CD19 and CD79b but did express B220 (CD45). Cell surface immunoglobulin (a mature B cell marker) was negative. The leukaemias were, however, positive for the myeloid marker Mac-1 and also expressed the panhemopoietic progenitor marker c-kit. Figure 4 shows a typical pro®le of the immunophenotypic characteristics observed on spleen cells from an Em-BCL-2 mouse treated with 2 Gy at 4 weeks of age. The single leukaemia to develop in adult mice irradiated at 2 Gy and which had non-rearranged IGH genes also had an indistinctive immunophenotype (but with a lymphoblastic morphology). The nature of this leukaemia is therefore unknown. Additionally, we cannot ascribe this single leukaemia (out of 35 in the group) to activity of the BCL-2 transgene as a few (2/50) non- Figure 2 Time course of leukaemia development in Em-BCL-2 mice following X-irradiation at 4 ± 6 weeks of age Table 2 Appearance of leukaemia after 12 months in Em-BCL-2 transgenic mice after X-irradiation of 4 ± 6 month-old mice Figure 3 Clonal IGH gene rearrangements in leukaemic cells of Em-BCL-2 mice. Southern blot probing of EcoRI restriction fragments with J H probe. Rearrangements are mono-allelic (mouse #150), bi-allelic (mouse #461) or tri-allelic (mouse #765). Mes, mesenteric lymph node; ing, inguinal lymph node transgenic mice also developed leukaemia following 2 Gy irradiation.
Molecular cytogenetics of leukaemias
Leukaemic cells from several Em-BCL-2 mice were examined for chromosomal alterations. Banded karyotype analysis (data not shown) suggested a consistent alteration which could have been interpreted as either tetrasomy 15 plus monosomy 4 or trisomy 15 plus an interstitial deletion of one copy of chromosome 4. FISH tests con®rmed, however, that the abnormality was trisomy 15 plus a deletion on one copy of chromosome 4 ( Figure 5 ). Metaphases from four leukaemic mice (three irradiated at 2 Gy, one at 4 Gy) were examined and all showed that same double chromosome abnormality.
Two regions of chromosome 4 are frequently deleted in radiation-induced mouse thymic lymphomas, and minimally deleted regions mapped to positions 40 ± 45 cM (TLSR1) and 64 ± 68 cM (TLSR2) (Santos et al., 1996) . Control DNA (tail) from six leukaemias which arose in irradiated Em-BCL-2 transgenic mice were genotyped using chromosomes 4 and 15-speci®c polymorphic micro-satellite markers.
All six mice were homozygous distal to D4Mit286 at 50 cM, and four (#461, 530, 797 and 767) were heterozygous proximal to D4Mit286. LOH analysis, comparing control and leukaemic spleen DNA at the D4Mit286 locus, was performed using [a-32 P]-dATP incorporation ( Figure 6a ) and/or ethidium bromide staining (Figure 6b) , and allelic imbalance detected in 4/4 informative leukaemias. Semi-quantitative PCR analysis comparing the [a-32 P]-dATP incorporation into the CBA and C57 alleles in (CBA6C57)F1 control DNA (CBA/C57=1) and leukaemic spleen DNA revealed loss of the CBA allele in leukaemia #461 (CBA/C57=0.22) and loss of the C57 allele in leukaemias #797 (CBA/C57=2.7) and #767 (CBA/ C57=2.4). The detection of allelic imbalance rather than loss of heterozygosity is attributed to varying degrees of contamination by normal cells in the leukaemic spleen at the time of sacri®ce. As hypermethylation of the p15
INK4b multi-tumour suppressor gene promoter (TLSR1) has been detected in *40% of radiation-induced thymic lymphomas (Malumbres et al., 1997) , three leukaemic DNA samples (#461, 767 and 797) were tested for p15 INK4b promoter methylation by Southern blot analysis. Methylation at a single promoter region XhoI site was not detected, although it is unclear whether the result is statistically signi®cant.
Control DNA from only two Em-BCL-2 mice which developed leukaemias showed regions of chromosome 15 heterozygosity. Micro-satellite (D15Mit111) analysis revealed that both leukaemias were also heterozygous. Quantitation of the PCR products of one leukaemia (#461) revealed a *1 : 2 ratio of the C57BL/6:CBA/H This genotype will include some nonleukaemic cells with germline (G) IGH genes. Bi-allelic rearrangements (R : R) could either aect one leukaemic clone with two alleles rearranged or two leukaemic clones each with one allele rearranged alleles (data not shown), indicating that trisomy 15 can occur by the duplication of one chromosome 15 allele rather than the loss of one allele and the triplication of the other.
Discussion
Murine B cell precursors normally express low levels of anti-apoptotic proteins BCL-2 and BCL-X L (large) and are vulnerable to apoptosis induced by corticosteroid or genotoxic agents (Griths et al., 1994a; Nishii et al., 1998; Vaux et al., 1988) . Sensitivity is maximal at the IL7-dependent pre-B cell stage when IGH gene rearrangement is occurring (Nishii et al., 1998; NunÄ ez et al., 1994) ; here a single traversal by one plutonium a particle or as few as 10 double-stranded DNA breaks following X-irradiation is lethal (Griths et al., 1994b) . In the presence of a human BCL-2 transgene (Vaux et al., 1988) or in the absence of p53-inducible expression (p53 knockout mice) (Griths et al., 1997) , clonogenic B cell precursors are markedly more resistant.
This pattern of sensitivity suggests that apoptosis might subvert or pre-empt transformation following genotoxic exposure in this cell type. If correct, this would have important implications for the possible aetiology of childhood ALL. The causation of this, the major subtype of paediatric cancer, is unknown; an abnormal response to infection is suspected (Greaves, 1997) but one of the few known causes is, in fact, ionizing radiation (Boice and Inskip, 1996) . A small but insigni®cant (61.4) increase in ALL (and AML) is associated with pre-natal diagnostic exposure (Doll and Wakeford, 1997) and an increased risk of ALL followed by exposure of children (515 years) to the atomic bomb in Japan (Boice and Inskip, 1996) . We reasoned that with apoptosis inhibited in B lineage cells by constitutive over-expression of a BCL-2 transgene, genotoxic damage might lead to an alternative pathway of DNA repair, mis-repair or mutation. This possibility was endorsed by the precedent that abrogation of the irradiation-induced apoptotic pathway in lymphoid cells via loss of p53 results in survival of Xirradiation-induced clonogenic mutants (Griths et al., 1997) , a high level of spontaneous leukaemia (Donehower et al., 1992; Jacks et al., 1994; Purdie et al., 1994) and an accelerated X-irradiation-induced leukaemia in young homozygous (7/7) or heterozygous (+/7) p53 knockout mice (Kemp et al., 1994) .
Our experiments con®rmed these expectations with a high rate of leukaemia in Em-BCL-2 mice irradiated with either 2 or 4 Gy. A much higher rate of leukaemia was however observed in very young (4 ± 6 weeks) as opposed to adult mice. In this respect, the observations parallel the age dependent increase in ALL following the atomic bomb exposure in Japan in 1945 (Boice and Inskip, 1996) . One possible explanation for this eect is the markedly higher level of B lymphopoiesis in young as opposed to adult rodents (Osmond, 1993) , i.e. a greater number of available`target' cells. Somewhat surprisingly however, the leukaemic cells were not all unambiguously B lineage aliated. Two leukaemias tested were of pre-B or mature B immunophenotype but the majority had a primitive phenotype despite having clonal IGH gene rearrangements. We interpret these results as re¯ecting transformation and differentiation arrest of primitive B lympho-myeloid progenitor cells but have so far been unable to con®rm this developmental status by the induction of dierentiation in vitro (DL Gibbons and LE Healy, unpublished observations). A similar B lymphomyeloid leukaemic cell type was found in some spontaneous leukaemias in Em-BCL-2 mice (Strasser et al., 1993) and more frequently when these mice were crossed with Em-MYC mice (Strasser et al., 1990 (Strasser et al., , 1996 . The immunophenotype of these leukaemic cells was, however, somewhat dierent in detail from that described here. Also, leukaemic cells from Em-BCL26Em-MYC were able to dierentiate into alternative B or myeloid lineage pathways in vitro under culture conditions to which our leukaemic cells appear unresponsive (Strasser et al., 1996) . It is possible also that the phenotype of leukaemia induced by irradiation is in¯uenced by genetic background of the mice. There is a substantial body of data that indicates that the susceptibility of dierent mouse strains to irradiationinduced leukaemia and the cell type of leukaemia that emerges is dependent upon genetic factors (Major and Mole, 1978; Upton et al., 1958) . Our Em-BCL-2 mice were back-crossed several times onto CBA. The latter strain is susceptible to X-irradiation-induced myeloid leukaemia with an average latency of *18 months (Alexander et al., 1995; Major and Mole, 1978) . Optimal dose of irradiation is 3 Gy with fewer leukaemias following 4 Gy radiation (Major and Mole, 1978) . We saw only two (5.2%) leukaemias in non-transgenic sibling mice during the 12 months after irradiation at 2 Gy which is compatible with the prior data. Clearly the presence of the Em-BCL-2 transgene confers a very substantial additional risk of leukaemia but we cannot rule out that the unexpected lymphomyeloid phenotype involved is in part attributable to the intrinsic susceptibility to myeloid leukaemia in mice with a CBA background.
The leukaemias induced in BCL-2 transgenic mice were clonal and had a consistent chromosomal abnormality; trisomy 15 plus an interstitial deletion of chromosome 4 con®rmed with micro-satellite markers. These are in fact relatively common chromosomal changes in thymic lymphomas induced by ionizing radiation (Santos et al., 1996; Wiener et al., 1978) . The molecular pathological consequences of trisomy 15 are unknown. We could detect no rearrangements (by Southern blot analysis; DL Gibbons unpublished data) of the c-MYC gene that resides on chromosome 15 and is known to complement BCL-2 transgene expression in leukaemogenesis (McDonnell and Korsmeyer, 1991; Strasser et al., 1990 Strasser et al., , 1993 . The loss of genetic material from chromosome 4 has been previously described in murine lymphomas (Malumbres et al., 1997; Santos et al., 1996) with evidence in some cases for inactivation, by methylation, or deletion or p15/p16 CDK4 INKa/1b genes (Zhuang et al., 1998) .
There are some potential important practical consequences of these data. First, a substantial proportion of normal adults have circulating lymphoid cells with an in frame IGH-BCL-2 gene fusion/ rearrangement (Ji et al., 1995; Liu et al., 1994) . This molecular abnormality is typical of mature B cell follicular lymphoma. These individuals, and the cells bearing this fusion gene with presumed constitutively activated BCL-2 protein, might be at increased risk of transformation following persistent antigenic drive or from, as our experiments suggest, genotoxic exposure. This risk will, we assume, be less than that in transgenic animals where all B lineage cells express deregulated BCL-2. Second, it has recently been shown that a BCL-2 transgene driven by an H-2K promoter can protect hemopoietic cells, including stem cells, from apoptosis induced by ionizing radiation (Domen et al., 1998) . The authors suggested that this might provide a strategy for eliminating or purging cancer cells whilst salvaging essential stem cells. Our data suggest that this would be a hazardous manoeuvre.
Materials and methods

Transgenic mice
Mice transgenic for the human BCL-2 gene (under the IG gene enhancer, Em-BCL-2 mice) were provided by Dr S Korsmeyer (McDonnell et al., 1989) and crossed in-house with CBA mice. Transgenic status was determined routinely by PCR of tail DNA using the following primer set: sense 5'-GGATGCCTTTGTGGAACTGTACG-3' anti-sense 5'-TTG-GGGCAGGCATGTTGACT-3'.
Transgenic mice and their non-transgenic littermates were subjected to X-rays (1 ± 4 Gy) using a Pantak source and observed for signs of illness for a subsequent period of 12 months. Age-matched controls were maintained for a total of 18 months.
Histopathology
Organs and tissues removed from the mice were ®xed in 10% buered formal saline, processed and then embedded in paran blocks. Five micron sections were then cut from each block, stained with haematoxylin and eosin and then examined microscopically.
Analysis of immunoglobulin gene rearrangement
Single cell suspensions were made from various organs of the mice by passing tissue through cell strainers. DNA was then extracted from these cells as described previously (Ford et al., 1988) . DNA was restricted with EcoRI and electrophoresed through 0.8% agarose gel. Hybridization was performed as described (Ford et al., 1988 ) using a 1.9 kb BamHI ± EcoRI fragment of the murine J H probe, P5 (Ford et al., 1992) .
Immuno¯uorescent staining
Cells were analysed for the expression of cell surface determinants using directly conjugated monoclonal antibodies against c-kit (PE anti-mouse, Pharmingen, UK), B220 (PE-anti-mouse, Pharmingen), surface Ig (FITC-anti-mouse, Southern Biotech Associates Inc, Birmingham, AL, USA), and Mac-1 (FITC-anti-mouse, Pharmingen) with appropriate antibodies as controls. Monoclonal antibodies also tested but not directly conjugated to a¯uorochrome included CD19 (ID3, rat IgG1, gift from Dr de Fougerolles, University of Cambridge, UK) and CD79b (HM79-12, biotin-anti-mouse, gift from M Koyama, University of Tokyo, Japan (Koyama et al., 1997) . Detection of bound antibody was performed using FITC-anti-rat (Southern Biotech Associates Inc) and avidin-FITC (Biogenesis, UK) respectively. Viable cells were assessed by gating on forward and side scatter and the results calculated from 10 4 acquired events using a FACScan¯ow cytometer (Becton Dickinson and Co, Mountain View, CA, USA).
Karyotyping analysis
Cells were placed in media overnight and colcemid was added to a ®nal concentration of 20 ng/ml 1 h before harvesting. A hypotonic solution of 0.5% KCL was added to the pellet for 20 min and the cells then ®xed twice in methanol : acetic acid (3 : 1). Cells were then resuspended in ®xative and dropped onto microscope slides. For FISH analysis, slides were washed in 70% formamide/26SSC for 2 min at 658C, air dried and probed with commercially available paints (Cambio, UK). For G-band analysis slides were aged 10 ± 14 days, incubated at 608C for 1 h in 26SSC, then stained in 5% Giemsa and 0.025% trypsin. Thirty metaphases per sample scored clonal aberration de®ned as same karyotype in three or more metaphases.
Micro-satellite mapping for LOH
Radioactive PCR was carried out as described by Fennelly et al. (1997) 
